Indeed, genetic alterations linked with poor prognosis [TP53, del(5q), complex karyotypes] and being more frequently encountered in AML-MRC, as well as AML-MRC per se were found to be associated with higher T cell induced cytolytic activity [34]. This evidence concerns the gene CD200 and acute myeloid leukemia.